Medicxi

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€500m

Latest public closing

14 Nov 2025

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Medicxi is a European life sciences venture capital firm, established in 2016 by the former Index Ventures life sciences team. It backs companies across the drug-development continuum.

Focus: Asset-centric biotechnology companies developing therapeutics for unmet medical needs

Medicxi announced the close of its €500 million Fund V in November 2025 (company announcement).